OCUL - Financial Reports List - Ocular Therapeutix, Inc. - IntrinsicAlpha

Ocular Therapeutix, Inc. OCUL

Healthcare - Biotechnology - NASDAQ - US

$ 7.61

4.1 %

$ 1.21 B

Market Cap

-6.24

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	15.40%	-65.60%	-152.26%
Annual Report	FY	10-K	2024-12-31	9.03%	-139.68%	-108.52%
Quarterly Report	Q3	8-K	2024-09-30	3.18%	-6972.29%	-139.40%
Quarterly Report	Q2	8-K	2024-06-30	8.26%	-111.67%	-111.91%
Quarterly Report	Q1	8-K	2024-03-31	10.03%	-78.16%	-40.21%
Quarterly Report	Q4	8-K	2023-12-31	5.16%	-149.25%	-3.55%
Annual Report	FY	10-K	2023-12-31	13.49%	-27.30%	-4.74%
Quarterly Report	Q3	8-K	2023-09-30	24.95%	98.08%	10.82%
Quarterly Report	Q2	8-K	2023-06-30	23.81%	-17.40%	-3.28%
Quarterly Report	Q1	8-K	2023-03-31	1.42%	-401.97%	-26.45%

1